z-logo
open-access-imgOpen Access
The Effects of Tibolone in Older Postmenopausal Women
Author(s) -
Steven R. Cummings,
Bruce Ettinger,
Pierre D. Delmas,
Peter Kenemans,
V. M. Stathopoulos,
Paul E. Verweij,
Mirjam Mol-Arts,
Lenus Kloosterboer,
Lori Mosca,
Claus Christiansen,
John Bilezikian,
Eduardo Kerzberg,
Susan R. Johnson,
José Zanchetta,
Diederich E. Grobbee,
Wilfried Seifert,
Richard Eastell
Publication year - 2008
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa0800743
Subject(s) - tibolone , medicine , hazard ratio , osteoporosis , breast cancer , relative risk , placebo , confidence interval , surgery , cancer , menopause , pathology , alternative medicine
Tibolone has estrogenic, progestogenic, and androgenic effects. Although tibolone prevents bone loss, its effects on fractures, breast cancer, and cardiovascular disease are uncertain.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom